ADT Logo

Arbeitsgemeinschaft Deutscher Tumorzentren e.V.

Netzwerk für Versorgung, Qualität und Forschung in der Onkologie

Kontakt
LinkIn Profil

Bild

Veröffentlichungen

Hier finden Sie eine Übersicht einiger Artikel.

Lacruz ME, Bedir A, Wittenberg I, et al. Determinants of synchronous and metachronous metastatic breast cancer (2000–2024)–an analysis based on data from German cancer registries. J Cancer Res Clin Oncol 2026; 152: 216. doi:10.1007/s00432-026-06631-5


Zeißig SR, Benz S, Hennings A, et al. Schaffung einer Plattform für eine bundesweite anlassbezogene Datenzusammenführung und -analyse in der Onkologie – PLATO 2 – Kurzkonzept. Gesundheitswesen 2026. doi:10.1055/a-2961-5956


Hansinger J, Schoffer O, Völkel V, et al. Survival Outcomes of Cervical Cancer Patients Treated in Certified Gynecologic Cancer Centers Versus Non-Certified Hospitals: Findings from a German Retrospective Cohort Study (WiZen). Geburtshilfe Frauenheilkd 2026; doi:10.1055/a-2957-5646


Hoffmann W, van den Berg N, Schmitt J, et al. Health research requires the linking of healthcare-related data. Gesundheitswesen 2026; doi:10.1055/a-2780-8325


Goßmann F, Beck N, Jakob J, et al. Evidence-based quality indicators of soft tissue sarcomas in Germany 2015-2021: An analysis of the German Cancer Registry Group. Eur J Surg Oncol 2026; 52: 111422. doi:10.1016/j.ejso.2026.111422


Duhn J, von Fritsch L, Honselmann KC, et al. Outcomes following adjuvant chemotherapy for distal bile duct carcinoma – A real-world data analysis from German Cancer Registries. Surgery 2026; 199: 110508. doi:10.1016/j.surg.2026.110508


von Fritsch L, Abual Naaj D, Duhn J, et al. Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? Cancers (Basel) 2026; 18: 2423. doi:10.3390/cancers18152423


Abdalla TSA, Kist M, Arify R, et al. Effect of multimodal therapy in the treatment of adenocarcinoma of the esophagus and gastroesophageal junction: a population-based analysis from the German Clinical Cancer Registry Group. Langenbecks Arch Surg 2026; 411: 148. doi:10.1007/s00423-026-04066-7


Beck N, Goßmann F, Hohenberger P, et al. Treatment of retroperitoneal sarcoma in Germany between 2000 and 2022: a retrospective analysis from the German Cancer Registry Group. J Cancer Res Clin Oncol 2026; 152: 90. doi:10.1007/s00432-026-06476-y


Wenning S, Gerken M, Papathemelis T, et al. Prognostic factors for lymph node infestation, long-term survival and recurrence rates in patients with vaginal cancer: a population-based study in Germany. J Cancer Res Clin Oncol 2026; 152: 63. doi:10.1007/s00432-026-06436-6


Piso T, Gerken M, Benz SR, et al. Elective surgery in rectal cancer: long term results of a German network comparison of open, laparoscopic, and robotic surgery. Eur J Surg Oncol 2026; 52: 111383. doi:10.1016/j.ejso.2026.111383


Seliger C, Schoffer O, Gerken M, et al. Survival of primary brain tumor patients according to treatment in certified oncologic centers. Cancer Treat Res Commun 2026; 48: 101352. doi:10.1016/j.ctarc.2026.101352


Schoffer O, Kemper M, Gerken M, et al. The effects of certification of head and neck cancer centers on the survival of patients with a head and neck cancer. BMC Cancer 2026; 26: 132. doi:10.1186/s12885-026-15624-z


Lwin MW, Schoffer O, Streissnig C, et al. A cost-effectiveness analysis of breast cancer treatment in certified versus non-certified hospitals in Germany. Int J Cancer 2026; 159: 159–172. doi:10.1002/ijc.70388

Doll C, Hofmann E, Trelinska-Finger A, et al. Benefit from adjuvant radiotherapy in early-stage oral cavity and oropharyngeal cancer with solitary ipsilateral lymph node metastasis – A population-based study on German cancer registry data. Oral Oncol 2025; 167: 107384. doi:10.1016/j.oraloncology.2025.107384


Duhn J, Strässer J, von Fritsch L, et al. Adjuvant Chemotherapy Is Associated with Improved Survival in Advanced Ampullary Adenocarcinoma - A Population-Based Analysis by the German Cancer Registry Group. J Clin Med 2025; 14: 3869. doi:10.3390/jcm14113869


Duhn J, von Fritsch L, Bolm L, et al. Perioperative and oncologic outcomes after total pancreatectomy and pancreatoduodenectomy for pancreatic head adenocarcinoma - A propensity score-matched analysis from the German Cancer Registry Group. Surgery 2025; 181: 109292. doi:10.1016/j.surg.2025.109292


Duhn J, von Fritsch L, Honselmann KC, et al. Oncologic outcomes and prognostic factors of colloid carcinoma of the pancreas - a retrospective real-world data analysis from the German cancer registry group of the society of German tumor centers. Langenbecks Arch Surg 2025; 410: 275. doi:10.1007/s00423-025-03870-x


Hansinger J, Schoffer O, Völkel V, et al. Comparison of survival in ovarian cancer patients following treatment in certified gynecologic oncology centers and non-certified hospitals: a German retrospective cohort study (WiZen). J Ovarian Res 2025; 18: 238. doi:10.1186/s13048-025-01843-8


Lacruz ME, Thies S, Schmidt-Pokrzywniak A, et al. Clinical characteristics, metastasis patterns, and treatment outcomes of HER2-low breast cancer. Sci Rep 2025; 15: 4584. doi:10.1038/s41598-025-88394-6


Langheinrich M, Gerken M, Robers G, et al. Survival benefit of adjuvant chemotherapy in elderly patients with UICC stage III colon carcinoma: A 20-year population-based German cohort study. Eur J Cancer 2025; 227: 115583. doi:10.1016/j.ejca.2025.115583


Soff J, Benz SR, Kowalski C, et al. Heterogeneity of treatment preferences in the absence of guideline recommendations – a case vignette study in colorectal cancer tumor boards in Germany, Austria and Switzerland. BMC Gastroenterol 2025; 25: 700. doi:10.1186/s12876-025-04183-5


Tinhofer I, Hofmann E, Trelinska-Finger A, et al. Trends and efficacy of definitive radiotherapy regimens for locally advanced head and neck cancer in elderly patients: A population-based analysis by the German cancer registry group. Eur J Cancer 2025; 230: 116039. doi:10.1016/j.ejca.2025.116039


Völkel V, Gerken M, Kleihues-van Tol K, et al. Long-term survival after treatment in certified lung cancer centers and not certified hospitals: Results of a large German cohort study using clinical routine data. Gesundheitswesen 2025; doi:10.1055/a-2624-0160


von Fritsch L, Duhn J, Abdalla TSA, et al. An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from the German Cancer Registry Group. Eur J Surg Oncol 2025; 51: 109693. doi:10.1016/j.ejso.2025.109693


Graf M, Gerken M, Klinkhammer-Schalke M, et al. Clinical, therapeutic and prognostic differences between male and female patients with breast cancer – a comparison of 2510 men and 307,634 women in a registry-based study in Germany. J Cancer Res Clin Oncol 2025; 151: 181. doi:10.1007/s00432-025-06220-y (Daten aus 18 klinischen Krebsregistern, 2000–2018)


Müller JA, Delank KS, Laudner K, et al. Treatment strategies for extremity sarcoma patients: a population-based analysis on German clinical cancer registry data. Front Oncol 2025; 15: 1555502. doi:10.3389/fonc.2025.1555502

Abdalla TSA, Bolm L, Klinkhammer-Schalke M, et al. When Should Lymphadenectomy Be Performed in Non-Metastatic Pancreatic Neuroendocrine Tumors? A Population-Based Analysis of the German Clinical Cancer Registry Group. Cancers (Basel) 2024; 16: 440. doi:10.3390/cancers16020440 https://doi.org/10.3390/cancers16020440


Abdalla TSA, Duhn J, Klinkhammer-Schalke M, et al. Oncological Outcomes and Patterns of Recurrence after the Surgical Resection of an Invasive Intraductal Papillary Mucinous Neoplasm versus Primary Pancreatic Ductal Adenocarcinoma: An Analysis from the German Cancer Registry Group of the Society of German Tumor Centers. Cancers (Basel) 2024; 16: 2016. doi:10.3390/cancers16112016, https://doi.org/10.3390/cancers16112016


Bierbaum V, Bobeth C, Roessler M, et al. Treatment in certified cancer centers is related to better survival in patients with colon and rectal cancer: evidence from a large German cohort study. World J Surg Oncol 2024; 22: 11. doi:10.1186/s12957-023-03262-9


Hansinger J, Völkel V, Gerken M, et al. Endometrial Cancer - Long-Term Survival in Certified Cancer Centers and Non-Certified Hospitals: Comparative Analysis Based on a Large German Retrospective Cohort Study (WiZen). Geburtshilfe Frauenheilkd 2024; 84: 979–988. doi:10.1055/a-1869-2060, https://doi.org/10.1055/a-1869-2060


Lugnier C, Sommerlatte S, Attenberger U, et al. Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany. Oncol Res Treat 2024; 47: 296–305. doi:10.1159/000538171, https://doi.org/10.1159/000538171

Papathemelis T, Ortmann O, Kohl C, et al. Treatment of endometrial cancer from 2000 to 2020 in Germany: a retrospective population based cohort study. J Cancer Res Clin Oncol 2024; 150: 279. doi:10.1007/s00432-024-05772-9 


Petruch N, Servin Rojas M, Lillemoe KD, et al. The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A cross-validation study of two national registries. Surgery 2024; 175: 1120–1127. doi:10.1016/j.surg.2023.11.004


Schoffer O, Wimberger P, Gerken M, et al. Treatment in Certified Breast Cancer Centers Improves Chances of Survival of Patients with Breast Cancer: Evidence Based on Health Care Data from the WiZen Study. Geburtshilfe Frauenheilkd 2024; 84: 153–163. doi:10.1055/a-1869-1772

Abdalla TSA, Klinkhammer-Schalke M, Zeissig SR, et al. Prognostic factors after resection of locally advanced non-functional pancreatic neuroendocrine neoplasm: an analysis from the German Cancer Registry Group of the Society of German Tumor Centers. J Cancer Res Clin Oncol 2023; 149: 8535–8543. doi:10.1007/s00432-023-04785-0, https://doi.org/10.1007/s00432-023-04785-0


Abdalla TSA, Pieper L, Kist M, et al. Gastrointestinal stromal tumors of the upper GI tract: population-based analysis of epidemiology, treatment and outcome based on data from the German Clinical Cancer Registry Group. J Cancer Res Clin Oncol 2023; 149: 7461–7469. doi:10.1007/s00432-023-04690-6
https://doi.org/10.1007/s00432-023-04690-6


Bobeth C, Tol KK, Rößler M, et al. [Methodology and Attribution Success of a Data Linkage of Clinical Registry Data with Health Insurance Data]. Gesundheitswesen 2023; 85: S154–S161. doi:10.1055/a-1984-0085, https://doi.org/10.1055/a-1984-0085


Klinkhammer-Schalke M, Wesselmann S, Bruns J, et al. [Further Development and Interoperability in Oncological Care Structures, Quality Control and Research]. Gesundheitswesen 2023; 85: 649–656. doi:10.1055/a-1926-6818, https://doi.org/10.1055/a-1926-6818


Schmitt J, Klinkhammer-Schalke M, Bierbaum V, et al. Initial Cancer Treatment in Certified Versus Non-Certified Hospitals. Dtsch Arztebl Int 2023; 120: 647–654. doi:10.3238/arztebl.m2023.0169
https://doi.org/10.3238/arztebl.m2023.0169


Völkel V, Gerken M, Kleihues-van Tol K, et al. Treatment of Colorectal Cancer in Certified Centers: Results of a Large German Registry Study Focusing on Long-Term Survival. Cancers (Basel) 2023; 15: 4568. doi:10.3390/cancers15184568


Zeissig SR, Emrich K, Reinwald F, et al. Sarcoma Research with Cancer Registry Data: Data and Peculiarities of Germany in the Light of Other Countries. Oncol Res Treat 2023; 46: 370–381. doi:10.1159/000531724, https://doi.org/10.1159/000531724


Bierbaum V, Schmitt J, Klinkhammer-Schalke M, Schoffer O. Potenzialabschätzung für die Konzentration der Versorgung von Krebspatient:innen in Kliniken mit DKG-Zertifizierung mittels Überlebenszeitanalyse [Assessment of the Potential of Concentrating Cancer Care in Hospitals With Certification Through Survival Analysis]. Gesundheitswesen 2023; 85: S197–S204. doi:10.1055/a-2132-6797 (WiZen)

Christoph Bobeth, Kees Kleihues-van Tol, Martin Rößler, Veronika Bierbaum, Michael Gerken, Christian Günster, Patrik Dröge, Thomas Ruhnke, Monika Klinkhammer-Schalke, Jochen Schmitt, Olaf Schoffer

Erfolg des Datenlinkage von GKV-Daten und Daten klinischer Krebsregister im Rahmen des WiZen-Projekts


Reinacher-Schick A, Lugnier C, Piso P, et al. S1 Guideline for prioritization in gastrointestinal cancer care – scarcity of resources in the pandemic context 

S1 Guideline for prioritization in gastrointestinal cancer care – scarcity of resources in the pandemic context


Braun R, Klinkhammer-Schalke M, Zeissig SR, et al. Clinical Outcome and Prognostic Factors of Pancreatic Adenosquamous Carcinoma Compared to Ductal Adenocarcinoma – Results from the German Cancer Registry Group. Cancers (Basel) 2022; 14: 3946. doi:10.3390/cancers14163946


Acs M, Gerken M, Gajic I, et al. Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Langenbecks Arch Surg 2022. doi:10.1007/s00423-022-02594-6


Roessler M, Schmitt J, Bobeth C, et al. Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study. BMC Cancer 2022; 22: 621. doi:10.1186/s12885-022-09731-w


Gennari P, Tchaikovski S, Mészáros J, et al. Protective effect of pre-operative conization in patients undergoing surgical treatment for early-stage cervical cancer. Gynecol Oncol 2022; 166: 57–60. doi:10.1016/j.ygyno.2022.05.014


Spoerl S, Gerken M, Chamilos C, et al. Clinical significance of panendoscopy in initial staging of oral squamous cell carcinoma and detection of synchronous second malignancies of the upper aerodigestive tract – Insights from a retrospective population-based cohort study. J Craniomaxillofac Surg 2022; 50: 515–522. doi:10.1016/j.jcms.2022.04.001


Fante MA, Felsenstein M, Mayer S, et al. All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma. Front Oncol 2022; 12: 852987. doi:10.3389/fonc.2022.852987


Filippini Velázquez G, Schiele S, Gerken M, et al. Predictive preoperative clinical score for patients with liver-only oligometastatic colorectal cancer. ESMO Open 2022; 7: 100470. doi:10.1016/j.esmoop.2022.100470


Deichmann S, Dworschak O, Kulemann B, et al. Incidence, Treatment and Survival in Pancreatic Cancer – Data of the Nationwide Oncological Quality Conference from a Surgical Perspective. Zentralbl Chir 2022; 147: 147–154. doi:10.1055/a-1768-1012


Bolm L, Zemskov S, Zeller M, et al. Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer – A Cross-Validation of the National Cancer Database (NCDB) and the German Cancer Registry Group of the Society of German Tumor Centers (GCRG/ADT). Cancers (Basel) 2022; 14: 868. doi:10.3390/cancers14040868


Spoerl S, Spoerl S, Reil S, et al. Prognostic Value of Perineural Invasion on Survival and Recurrence in Oral Squamous Cell Carcinoma. Diagnostics (Basel) 2022; 12: 1062. doi:10.3390/diagnostics12051062


Röhrmoser K, Ignatov A, Gerken M, et al. Risk factors and temporal patterns of recurrences in patients with vulvar cancer: implications for follow-up intervals and duration. J Cancer Res Clin Oncol 2022 (Print 2023). doi:10.1007/s00432-022-03954-x


Acs M, Halmy L, Isgandarova S, et al. Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes Versus 60 Minutes After Cytoreductive Surgery (CRS). Does the 30-Minute Difference Matter? A Comparative Study in a High Volume Centre. Anticancer Res 2022; 42: 1019–1029. doi:10.21873/anticanres.15563


Kist M, Thomaschewski M, Keck Y, et al. Specifics of Young Gastric Cancer Patients: A Population-Based Analysis of 46,110 Patients with Gastric Cancer from the German Clinical Cancer Registry Group. Cancers (Basel) 2022; 14: 5927. doi:10.3390/cancers14235927


WiZen-Konsortium. Ergebnisbericht zum Innovationsfonds-Projekt „Wirksamkeit der Versorgung in onkologischen Zentren (WiZen)“. Innovationsausschuss beim G-BA, 17.10.2022. PDF (Projektbericht, keine Zeitschriftenpublikation)

Voigtländer S, Hakimhashemi A, Inwald EC, et al. The Impact of the COVID-19 Pandemic on Cancer Incidence and Treatment by Cancer Stage in Bavaria, Germany. Dtsch Arztebl Int 2021; 118: 660–661. doi:10.3238/arztebl.m2021.0329


Völkel V, Klinkhammer-Schalke M, Fürst A. Falling Mortality Thanks to Improved Treatment for Colorectal Cancer. Dtsch Arztebl Int 2021; 118: 664. doi:10.3238/arztebl.m2021.0259


Spoerl S, Spanier G, Reiter E, et al. Head and neck melanoma: outcome and predictors in a population-based cohort study. Head Face Med 2021; 17: 45. doi:10.1186/s13005-021-00295-x


Scharl S, Sprötge T, Gerken M, et al. Factors influencing treatment decision and guideline conformity in high-grade endometrial cancer patients: a population-based study. Arch Gynecol Obstet 2021. doi:10.1007/s00404-021-06140-5


Lindberg-Scharf P, Steinger B, Koller M, et al. Long-term improvement of quality of life in patients with breast cancer: supporting patient-physician communication by an electronic tool for inpatient and outpatient care. Support Care Cancer 2021. doi:10.1007/s00520-021-06270-1


Windschüttl S, Pukrop T, Herrmann A, et al. Entwicklung eines Screening-Workflows zur Erfassung von Patientenbedürfnissen in einer interdisziplinären onkologischen Tagesklinik. Z Evid Fortbild Qual Gesundhwes 2021; 163: 30–37. doi:10.1016/j.zefq.2021.04.004


Scharl S, Gerken M, Sprötge T, et al. Comparison of survival outcomes and effects of therapy between subtypes of high-grade endometrial cancer – a population-based study. Acta Oncol 2021. doi:10.1080/0284186X.2021.1914347


Markowiak T, Dakkak B, Loch E, et al. Video-assisted pulmonary metastectomy is equivalent to thoracotomy regarding resection status and survival. J Cardiothorac Surg 2021; 16: 84. doi:10.1186/s13019-021-01460-8


Markowiak T, Neu R, Ansari MKA, et al. Surgical cytoreduction and HITOC for thymic malignancies with pleural dissemination. Thorac Cardiovasc Surg 2021; 69: 157–164. doi:10.1055/s-0039-1700883


Hetterich M, Gerken M, Ortmann O, et al. Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases. Breast Cancer Res Treat 2021. doi:10.1007/s10549-021-06162-2


Finke I, Behrens G, Maier W, et al. Small-area analysis on socioeconomic inequalities in cancer survival for 25 cancer sites in Germany. Int J Cancer 2021. doi:10.1002/ijc.33553


Völkel V, Schatz S, Draeger T, et al. Transanal total mesorectal excision: short- and long-term results of the first hundred cases of a certified colorectal cancer center in Germany. Surg Endosc 2021. doi:10.1007/s00464-021-08384-3


Scharl S, Becher C, Gerken M, et al. Is there a benefit for adjuvant radio(chemo)therapy in early cervical cancer? Results from a population-based study. Arch Gynecol Obstet 2021. doi:10.1007/s00404-021-05989-w


Gennari P, Gerken M, Mészáros J, et al. Minimal-invasive or open approach for surgery of early cervical cancer: the treatment center matters. Arch Gynecol Obstet 2021. doi:10.1007/s00404-020-05947-y


Spanier G, Ugele I, Nieberle F, et al. The predictive power of CD3+ T cell infiltration of oral squamous cell tumors is limited to non-diabetic patients. Cancer Lett 2021 (online 2020). doi:10.1016/j.canlet.2020.11.029


Petrova E, Wellner J, Nording AK, et al. Survival Outcome and Prognostic Factors for Pancreatic Acinar Cell Carcinoma: Retrospective Analysis from the German Cancer Registry Group. Cancers (Basel) 2021; 13: 6121. doi:10.3390/cancers13236121


Hellmund P, Schmitt J, Roessler M, Meier F, Schoffer O. Targeted and Checkpoint Inhibitor Therapy of Metastatic Malignant Melanoma in Germany, 2000–2016. Cancers (Basel) 2020; 12: 2354. doi:10.3390/cancers12092354


Robold T, Neumeier J, Ried M, et al. Chirurgische Therapie des Lungenkarzinoms: Wie wirkt sich die Einführung der 8. TNM-Klassifikation auf die leitliniengerechte Therapie aus? Zentralbl Chir 2020; 145: 589–596. doi:10.1055/a-1164-7058


Staubach P, Scharl A, Ignatov A, et al. Sentinel lymph node detection by means of indocyanine green using the Karl Storz VITOM® fluorescence camera: a comparison between primary sentinel lymph node biopsy versus sentinel lymph node biopsy after neoadjuvant chemotherapy. J Cancer Res Clin Oncol 2020. doi:10.1007/s00432-020-03461-x


Spoerl S, Gerken M, Fischer R, et al. Lymphatic and vascular invasion in oral squamous cell carcinoma: Implications for recurrence and survival in a population-based cohort study. Oral Oncol 2020; 111: 105009. doi:10.1016/j.oraloncology.2020.105009


Reinert C, Gerken M, Rathberger K, et al. Single-institution cross-sectional study to evaluate need for information and need for referral to psychooncology care in association with depression in brain tumor patients and their family caregivers. BMC Psychol 2020; 8: 96. doi:10.1186/s40359-020-00460-y


Völkel V, Draeger T, Gerken M, et al. Laparoscopic surgery for colon cancer – A systematic review with special focus on real-world data. coloproctology 2020. doi:10.1007/s00053-020-00481-6


Teufel A, Gerken M, Fürst A, et al. Benefit of adjuvant chemotherapy in high-risk colon cancer: A 17-year population-based analysis of 6131 patients with Union for International Cancer Control stage II T4N0M0 colon cancer. Eur J Cancer 2020; 137: 148–160. doi:10.1016/j.ejca.2020.06.036


Spoerl S, Gerken M, Mamilos A, et al. Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study. Clin Oral Investig 2020. doi:10.1007/s00784-020-03471-6


Jansen L, Behrens G, Finke I, et al. Area-Based Socioeconomic Inequalities in Colorectal Cancer Survival in Germany: Investigation Based on Population-Based Clinical Cancer Registration. Front Oncol 2020; 10: 857. doi:10.3389/fonc.2020.00857


Spanier G, Böttcher J, Gerken M, et al. Prognostic value of perioperative red blood cell transfusion and anemia on survival and recurrence in oral squamous cell carcinoma. Oral Oncol 2020; 107: 104773. doi:10.1016/j.oraloncology.2020.104773


Prantl L, Gerken M, Zeman F, et al. Incidence of Anaplastic Large Cell Lymphoma and Breast-Implant-Associated Lymphoma – An Analysis of a Certified Tumor Registry over 17 Years. J Clin Med 2020; 9: 1247. doi:10.3390/jcm9051247


Klinkhammer-Schalke M, Steinger B, Koller M, et al. Diagnosing deficits in quality of life and providing tailored therapeutic options: Results of a randomised trial in 220 patients with colorectal cancer. Eur J Cancer 2020; 130: 102–113. doi:10.1016/j.ejca.2020.01.025


Papathemelis T, Scharl A, Anapolski M, et al. Value of indocyanine green pelvic lymph node mapping in the surgical approach of cervical cancer. Arch Gynecol Obstet 2020. doi:10.1007/s00404-020-05457-x


Finke I, Behrens G, Schwettmann L, et al. Socioeconomic differences and lung cancer survival in Germany: Investigation based on population-based clinical cancer registration. Lung Cancer 2020; 142: 1–8. doi:10.1016/j.lungcan.2020.01.021


Schmuck R, Gerken M, Teegen EM, et al. Gender comparison of clinical, histopathological, therapeutic and outcome factors in 185,967 colon cancer patients. Langenbecks Arch Surg 2020; 405: 71–80. doi:10.1007/s00423-019-01850-6


Papathemelis T, Oppermann H, Grafl S, et al. Long-term outcome of patients with intermediate- and high-risk endometrial cancer after pelvic and paraaortic lymph node dissection: a comparison of laparoscopic vs. open procedure. J Cancer Res Clin Oncol 2020. doi:10.1007/s00432-019-03122-8


Gebauer A, Barlag H, Wesselmann S, et al. Berechenbarkeit der Qualitätsindikatoren der onkologischen S3-Leitlinien mit dem ADT-/GEKID-Basisdatensatz und seiner Zusatzmodule [Evaluation of Quality Indicators of Evidence-Based Guidelines Using ADT/GEKID Base Dataset and its Organ-Specific Modules]. Gesundheitswesen 2020; 82: 710–715. doi:10.1055/a-1010-5426


Schnitzbauer V, Gerken M, Benz S, et al. Laparoscopic and open surgery in rectal cancer patients in Germany: short and long-term results of a large 10-year population-based cohort. Surg Endosc 2020; 34: 1132–1141. doi:10.1007/s00464-019-06861-4

Völkel V, Draeger T, Schnitzbauer V, et al. Surgical treatment of rectal cancer patients aged 80 years and older – a German nationwide analysis comparing short- and long-term survival after laparoscopic and open tumor resection. Eur J Surg Oncol 2019. doi:10.1016/j.ejso.2019.05.005


Voelkel V, Draeger T, Groothuis-Oudshoorn CGM, et al. Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany. J Cancer Res Clin Oncol 2019. doi:10.1007/s00432-019-02904-4


Papathemelis T, Knobloch S, Gerken M, et al. Impact of nodal status and treatment strategy on overall survival in advanced stage cervical cancer. J Cancer Res Clin Oncol 2019. doi:10.1007/s00432-019-02890-7


Draeger T, Völkel V, Schnitzbauer V, et al. Laparoscopic and open resection of rectal cancer – is age an effect modifier for short- and long-term survival? Int J Colorectal Dis 2019. doi:10.1007/s00384-019-03265-7


Wimmer T, Ortmann O, Gerken M, et al. Adherence to guidelines and benefit of adjuvant radiotherapy in patients with invasive breast cancer: results from a large population-based cohort study of a cancer registry. Arch Gynecol Obstet 2019. doi:10.1007/s00404-018-5030-z

Seliger C, Schaertl J, Gerken M, et al. Use of statins or NSAIDs and survival of patients with high-grade glioma. PLoS One 2018; 13: e0207858. doi:10.1371/journal.pone.0207858


Piso P, Stierstorfer K, Gerken M, Klinkhammer-Schalke M. Benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancer. Int J Colorectal Dis 2018. doi:10.1007/s00384-018-3146-z


Seliger C, Luber C, Gerken M, et al. Use of metformin and survival of patients with high-grade glioma. Int J Cancer 2018 (Print 2019). doi:10.1002/ijc.31783


Papathemelis T, Hassas D, Gerken M, et al. Is there a benefit of lymphadenectomy for overall and recurrence-free survival in type I FIGO IB G1-2 endometrial carcinoma? A retrospective population-based cohort analysis. J Cancer Res Clin Oncol 2018. doi:10.1007/s00432-018-2715-4


Ott C, Gerken M, Hirsch D, et al. Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment. Digestion 2018; 98: 143–152. doi:10.1159/000487710


Munker S, Gerken M, Fest P, et al. Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects. BMC Cancer 2018; 18: 455. doi:10.1186/s12885-018-4380-z


Völkel V, Draeger T, Gerken M, et al. Langzeitüberleben von Patienten mit Kolon- und Rektumkarzinomen: Ein Vergleich von Darmkrebszentren und nicht zertifizierten Krankenhäusern. Gesundheitswesen 2018. doi:10.1055/a-0591-3827


Draeger T, Völkel V, Gerken M, et al. Long-term oncologic outcomes after laparoscopic versus open rectal cancer resection: a high-quality population-based analysis in a Southern German district. Surg Endosc 2018. doi:10.1007/s00464-018-6148-6


Völkel V, Draeger T, Gerken M, et al. Long-term oncologic outcomes after laparoscopic vs. open colon cancer resection: a high-quality population-based analysis in a Southern German district. Surg Endosc 2018. doi:10.1007/s00464-018-6158-4


Reinert C, Rathberger K, Klinkhammer-Schalke M, et al. Information needs and requirements in patients with brain tumours and their relatives. J Neurooncol 2018. doi:10.1007/s11060-018-2811-y


Liebig-Hörl G, Puchner C, Gerken M, et al. Therapeutische Strategie bei Frühkarzinom im Rektum (T1-Karzinom). Chirurg 2018. doi:10.1007/s00104-018-0603-8


Papathemelis T, Jablonsky E, Hauzenberger T, et al. Sentinel lymph node biopsy (SLNB) in breast cancer patients by means of indocyanine green (ICG) using the Karl Storz VITOM fluorescence camera. Biomed Res Int 2018; 2018: 6251468. doi:10.1155/2018/6251468


Scharl S, Papathemelis T, Kronberger K, et al. Does post-operative radiochemotherapy improve survival in high-grade endometrial cancer patients? Results of a population-based cohort analysis of a cancer registry. Arch Gynecol Obstet 2018. doi:10.1007/s00404-018-4708-6

 

Haj A, Doenitz C, Schebesch KM, et al. Extent of Resection in Newly Diagnosed Glioblastoma: Impact of a Specialized Neuro-Oncology Care Center. Brain Sci 2018; 8: 5 (online Dezember 2017). doi:10.3390/brainsci8010005


Papathemelis T, Scharl S, Kronberger K, et al. Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis. J Cancer Res Clin Oncol 2017. doi:10.1007/s00432-017-2508-1


Klinkhammer-Schalke M, Steinger B, Koller M, Lindberg P. Lebensqualitätsinterventionen in der Onkologie. Z Evid Fortbild Qual Gesundhwes 2017. doi:10.1016/j.zefq.2017.04.005


Lindberg P, Netter P, Koller M, et al. Breast cancer survivors' recollection of their quality of life: identifying determinants of recall bias in a longitudinal population-based trial. PLoS One 2017. doi:10.1371/journal.pone.0171519


Inwald EC, Ortmann O, Koller M, et al. Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology. Breast Cancer Res Treat 2017; 163: 119–130. doi:10.1007/s10549-017-4151-6


Klinkhammer-Schalke M, Gerken M, Barlag H, et al. Bedeutung von Krebsregistern für die Versorgungsforschung – Registerstudien vs. klinische Studien am Beispiel des Kolonkarzinoms. Onkologe 2017; 23: 280–287. doi:10.1007/s00761-016-0181-7


Benz S, Barlag H, Gerken M, Fürst A, Klinkhammer-Schalke M. Laparoscopic surgery in patients with colon cancer: a population-based analysis. Surg Endosc 2017; 31: 2586–2595. doi:10.1007/s00464-016-5266-2 (Daten aus 30 regionalen Krebsregistern)


Schoffer O, Schülein S, Arand G, et al. Tumour stage distribution and survival of malignant melanoma in Germany 2002–2011. BMC Cancer 2016; 16: 936. doi:10.1186/s12885-016-2963-0 (gepoolte Daten aus 28 klinischen Krebsregistern)


Klinkhammer-Schalke M, Hofstädter F, Gerken M, Benz S. Der Beitrag Klinischer Krebsregister für die Nutzenbewertung – Anforderungen und erste Ergebnisse. Z Evid Fortbild Qual Gesundhwes 2016; 112 Suppl 1: S3–S10. doi:10.1016/j.zefq.2016.04.008


Klinkhammer-Schalke M, Gerken M, Barlag H, Tillack A. Was können Klinische Krebsregister in Zukunft für die bevölkerungsbezogene Umsetzung evidenzbasierter Leitlinien leisten? [Quality management in oncology supported by clinical cancer registries]. Z Evid Fortbild Qual Gesundhwes 2015; 109: 452–458. doi:10.1016/j.zefq.2015.08.001 (auf der Seite unter 2017)


Lindberg P, Koller M, Steinger B, et al. Breast cancer survivors' recollection of their illness and therapy seven years after enrolment into a randomised controlled clinical trial. BMC Cancer 2015; 15: 554. doi:10.1186/s12885-015-1573-6


Ortmann O, Buchholz S, Klinkhammer-Schalke M. Der Nationale Krebsplan – Ziele, Umsetzung und Konsequenzen. Chirurgische Praxis 2014; 78 (1).


Klinkhammer-Schalke M, Lindberg P, Koller M, et al. Lebensqualität bei Brustkrebs-Patientinnen – Implementierung und Umsetzung in die Routineversorgung. Geburtshilfe Frauenheilkd 2014; 74.

Lange R, Matthes C, Schmieder G, et al. Fit für die Umsetzung des Krebsfrüherkennungs- und -registergesetzes? Mitteilungsblatt der Sächsischen Krebsgesellschaft 2014; Ausgabe 2/2014.


Hofstädter F, Hentschel S. Klinische und epidemiologische Krebsregister: Zwei sich ergänzende Informationsquellen zum Krebsgeschehen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2014; 57: 27–32. doi:10.1007/s00103-013-1871-6


Inwald EC, Klinkhammer-Schalke M, Hofstädter F, et al. Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat 2013; 139: 539–552. doi:10.1007/s10549-013-2560-8


Klinkhammer-Schalke M, Katalinic A. Der Nationale Krebsplan aus Sicht der klinischen und epidemiologischen Register. mdi – Forum der Medizin-Dokumentation und Medizin-Informatik 2013; 15 (2).


Blum T, Schönfeld N, Goeckenjan G, Jagota A. Umsetzung der S3-Leitlinie zur Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms im Land Berlin. Pneumologie 2013; 67: 118–122.


Blum T. Versorgungssituation beim Lungenkarzinom in Deutschland – Ergebnisse einer Auswertung bundesweiter Daten klinischer Krebsregister. Abstract, 54. Kongress der DGP, Hannover 2013.


Blum TG, Schönfeld N, Jagota A, Klinkhammer-Schalke M. Integration und Steuerfunktion klinischer Krebsregister in der onkologischen Versorgung. Forum 2012; 27: 431–435. doi:10.1007/s12312-012-0897-2


Klinkhammer-Schalke M, Marschner N, Hofstädter F. Register in der onkologischen Versorgungsforschung. Onkologe 2012; 18: 142–150. doi:10.1007/s00761-011-2197-3


Wittekind C, Hofstädter F. Optimale Zusammenarbeit von Klinikern und Pathologen in der Tumordiagnostik. Forum 2012; (1).


Hofstädter F, Klinkhammer-Schalke M. Aufgaben und Strukturen für die klinische Krebsregistrierung. Onkologe 2011; 17: 121–125.


Hölzel D. Versorgungsforschung mit Krebsregistern. Onkologe 2011; 17: 143–152.


Klinkhammer-Schalke M, Wesselmann S. Status quo der Zusammenarbeit von Klinischen Krebsregistern und Organkrebszentren. Forum 2010; (4).


Hofstädter F, Klinkhammer-Schalke M. Klinische Krebsregister – Neue Entwicklungen nach der Nationalen Krebskonferenz. Forum 2010; (2).


Klinkhammer-Schalke M. Kombination von medizinischen und hermeneutischen Ergebnissen in der Versorgungsforschung – Bessere Chancen für beides: Überleben und Lebensqualität. Forum 2009; (5).


Hofstädter F, Hölzel D. Was leisten Tumorregister für die Qualitätssicherung in der Onkologie? Onkologe 2008; 14: 1220 ff.


Hermanek P, Wagner G, Grundmann E, Hermanek P. Das Tumordokumentationssystem der Arbeitsgemeinschaft Deutscher Tumorzentren (ADT). Geburtshilfe Frauenheilkd 1996; 56: M42–M44. PubMed 8674952


Howaldt HP, Störkel S, Herrmann G. Standardisierte pathoanatomische Befunddokumentation auf den ADT-Tumorbögen für Malignome des Mundes, der Kiefer und des Gesichts (Version III). Pathologe 1995; 16: 391–397. doi:10.1007/s002920050119


Wagner G, Wiebelt H. Die Basisdokumentation der Tumorzentren. Lebensversicher Med 1982; 34: 169–174. PubMed 6128642